Rome, Italy - New trials of prophylactic implantable cardioverter defibrillator (ICD) therapy in seniors are needed, because the seminal studies of ICDs in heart-failure patients do not show a survival benefit in older patients, the authors of a new meta-analysis argue.Dr. Pasquale Santangelli (Catholic University of the Sacred Heart, Rome, Italy…
Read More